메뉴 건너뛰기




Volumn 36, Issue 3, 2010, Pages 243-246

Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates

Author keywords

Acinetobacter baumannii; Carbapenems; Combination therapy; Synergy

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; DORIPENEM; DOXYCYCLINE; IMIPENEM; MEROPENEM; MOXIFLOXACIN; NETILMICIN; RIFAMPICIN; SULPERAZON;

EID: 77954958314     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.04.011     Document Type: Article
Times cited : (37)

References (14)
  • 2
    • 57649234918 scopus 로고    scopus 로고
    • Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program
    • Mendes R.E., Bell J.M., Turnidge J.D., Castanheira M., Jones R.N. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program. J Antimicrob Chemother 2009, 63:55-59.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 55-59
    • Mendes, R.E.1    Bell, J.M.2    Turnidge, J.D.3    Castanheira, M.4    Jones, R.N.5
  • 3
    • 35848952749 scopus 로고    scopus 로고
    • Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study
    • Lee N.Y., Wang C.L., Chuang Y.C., Yu W.L., Lee H.C., Chang C.M., et al. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study. Pharmacotherapy 2007, 27:1506-1511.
    • (2007) Pharmacotherapy , vol.27 , pp. 1506-1511
    • Lee, N.Y.1    Wang, C.L.2    Chuang, Y.C.3    Yu, W.L.4    Lee, H.C.5    Chang, C.M.6
  • 4
    • 67649729676 scopus 로고    scopus 로고
    • In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
    • Principe L., D'Arezzo S., Capone A., Petrosillo N., Visca P. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob 2009, 8:18.
    • (2009) Ann Clin Microbiol Antimicrob , vol.8 , pp. 18
    • Principe, L.1    D'Arezzo, S.2    Capone, A.3    Petrosillo, N.4    Visca, P.5
  • 5
    • 37849040424 scopus 로고    scopus 로고
    • Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
    • Pankuch G.A., Lin G., Seifert H., Appelbaum P.C. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob Agents Chemother 2008, 52:333-336.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 333-336
    • Pankuch, G.A.1    Lin, G.2    Seifert, H.3    Appelbaum, P.C.4
  • 7
    • 0034061105 scopus 로고    scopus 로고
    • In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak
    • Appleman M.D., Belzberg H., Citron D.M., Heseltine P.N., Yellin A.E., Murray J., et al. In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob Agents Chemother 2000, 44:1035-1040.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 1035-1040
    • Appleman, M.D.1    Belzberg, H.2    Citron, D.M.3    Heseltine, P.N.4    Yellin, A.E.5    Murray, J.6
  • 8
    • 1442349053 scopus 로고    scopus 로고
    • Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates
    • Jung R., Husain M., Choi M.K., Fish D.N. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 2004, 48:1055-1057.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 1055-1057
    • Jung, R.1    Husain, M.2    Choi, M.K.3    Fish, D.N.4
  • 9
    • 32644481380 scopus 로고    scopus 로고
    • In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units
    • Timurkaynak F., Can F., Azap O.K., Demirbilek M., Arslan H., Karaman S.O. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 2006, 27:224-228.
    • (2006) Int J Antimicrob Agents , vol.27 , pp. 224-228
    • Timurkaynak, F.1    Can, F.2    Azap, O.K.3    Demirbilek, M.4    Arslan, H.5    Karaman, S.O.6
  • 10
    • 0029800028 scopus 로고    scopus 로고
    • Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test
    • White R.L., Burgess D.S., Manduru M., Bosso J.A. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 1996, 40:1914-1918.
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 1914-1918
    • White, R.L.1    Burgess, D.S.2    Manduru, M.3    Bosso, J.A.4
  • 11
    • 42549104674 scopus 로고    scopus 로고
    • Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology
    • Falagas M.E., Karageorgopoulos D.E. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008, 46:1121-1122.
    • (2008) Clin Infect Dis , vol.46 , pp. 1121-1122
    • Falagas, M.E.1    Karageorgopoulos, D.E.2
  • 12
    • 77954955056 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI
    • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
    • (2009)
  • 13
    • 0033802358 scopus 로고    scopus 로고
    • Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods
    • Bonapace C.R., White R.L., Friedrich L.V., Bosso J.A. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagn Microbiol Infect Dis 2000, 38:43-50.
    • (2000) Diagn Microbiol Infect Dis , vol.38 , pp. 43-50
    • Bonapace, C.R.1    White, R.L.2    Friedrich, L.V.3    Bosso, J.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.